Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver
Conclusions HAI irinotecan in combination with bevacizumab; oxaliplatin plus bevacizumab; or cetuximab plus bevacizumab was safe and may be a treatment option for selected patients with advanced cancer and liver involvement.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Drugs & Pharmacology | Eloxatin | Erbitux | Investigational New Drugs | Liver | Neurology | Non-Small Cell Lung Cancer | Pancreas | Pancreatic Cancer | Skin | Study | Thrombocytopenia | Toxicology | Urology & Nephrology